While North America continues to hold the largest share of the global testing landscape, the most explosive growth in 2026 is concentrated in the Asia-Pacific region. Driven by a massive expansion in biopharmaceutical manufacturing in China and India, the region is rapidly modernizing its laboratory infrastructure to meet international quality standards. This shift is not just about catching...
Portuguese 
English
Arabic
French
Spanish
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Tiếng Việt